NIGHTINGALE HEALTH EO 1 (7XE) - Net Assets
Based on the latest financial reports, NIGHTINGALE HEALTH EO 1 (7XE) has net assets worth €57.99 Million EUR (≈ $67.79 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€67.04 Million ≈ $78.38 Million USD) and total liabilities (€9.06 Million ≈ $10.59 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check NIGHTINGALE HEALTH EO 1 (7XE) asset resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €57.99 Million |
| % of Total Assets | 86.49% |
| Annual Growth Rate | -15.95% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 3.16 |
NIGHTINGALE HEALTH EO 1 - Net Assets Trend (2022–2025)
This chart illustrates how NIGHTINGALE HEALTH EO 1's net assets have evolved over time, based on quarterly financial data. Also explore NIGHTINGALE HEALTH EO 1 (7XE) total assets for the complete picture of this company's asset base.
Annual Net Assets for NIGHTINGALE HEALTH EO 1 (2022–2025)
The table below shows the annual net assets of NIGHTINGALE HEALTH EO 1 from 2022 to 2025. For live valuation and market cap data, see 7XE company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | €66.17 Million ≈ $77.36 Million |
-20.17% |
| 2024-06-30 | €82.88 Million ≈ $96.90 Million |
-14.87% |
| 2023-06-30 | €97.36 Million ≈ $113.82 Million |
-12.64% |
| 2022-06-30 | €111.44 Million ≈ $130.29 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to NIGHTINGALE HEALTH EO 1's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4543300000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €142.66 Million | 215.61% |
| Total Equity | €66.17 Million | 100.00% |
NIGHTINGALE HEALTH EO 1 Competitors by Market Cap
The table below lists competitors of NIGHTINGALE HEALTH EO 1 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Feytech Holdings Berhad
KLSE:5322
|
$47.63 Million |
|
Eniro AB
ST:ENRO
|
$47.63 Million |
|
Hong Yi Fiber Industry Co Ltd
TW:1452
|
$47.64 Million |
|
Nuveen New York Select Tax-Free Income Portfolio
NYSE:NXN
|
$47.65 Million |
|
H2APEX Group SCA
XETRA:H2A
|
$47.61 Million |
|
Transcontinental Inc
TO:TCL-B
|
$47.59 Million |
|
Spectral AI Inc.
NASDAQ:MDAI
|
$47.57 Million |
|
Yanaprima Hastapersada Tbk
JK:YPAS
|
$47.56 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in NIGHTINGALE HEALTH EO 1's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 82,881,000 to 66,166,000, a change of -16,715,000 (-20.2%).
- Net loss of 18,461,000 reduced equity.
- Other factors increased equity by 1,746,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-18.46 Million | -27.9% |
| Other Changes | €1.75 Million | +2.64% |
| Total Change | €- | -20.17% |
Book Value vs Market Value Analysis
This analysis compares NIGHTINGALE HEALTH EO 1's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.92x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.54x to 0.92x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-06-30 | €1.85 | €1.01 | x |
| 2023-06-30 | €1.61 | €1.01 | x |
| 2024-06-30 | €1.37 | €1.01 | x |
| 2025-06-30 | €1.10 | €1.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently NIGHTINGALE HEALTH EO 1 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -27.90%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -393.37%
- • Asset Turnover: 0.06x
- • Equity Multiplier: 1.13x
- Recent ROE (-27.90%) is below the historical average (-20.50%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | -14.44% | -695.68% | 0.02x | 1.11x | €-27.23 Million |
| 2023 | -18.57% | -432.40% | 0.04x | 1.10x | €-27.82 Million |
| 2024 | -21.07% | -400.71% | 0.05x | 1.10x | €-25.75 Million |
| 2025 | -27.90% | -393.37% | 0.06x | 1.13x | €-25.08 Million |
Industry Comparison
This section compares NIGHTINGALE HEALTH EO 1's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $105,330,486
- Average return on equity (ROE) among peers: -19.33%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| NIGHTINGALE HEALTH EO 1 (7XE) | €57.99 Million | -14.44% | 0.16x | $47.63 Million |
| CERTIVE SOLUTIONS INC. (5CE) | $-10.47 Million | 0.00% | 0.00x | $296.62K |
| IQ-AI LTD. LS -01 (5Y1) | $707.07K | -72.35% | 0.70x | $144.21K |
| TRELLUS HEALTH LS -0006 (85Q) | $11.77 Million | -66.13% | 0.03x | $159.96K |
| SPOTLITE360 IOT SOLUTIONS (87A0) | $5.83 Million | -68.78% | 0.33x | $916.43K |
| DocCheck AG (AJ91) | $39.41 Million | 15.96% | 0.61x | $58.35 Million |
| CompuGroup Medical SE & Co. KGaA (COP) | $673.82 Million | 10.89% | 1.89x | $1.17 Billion |
| MeVis Medical Solutions AG (M3V) | $32.51 Million | 17.29% | 0.51x | $45.14 Million |
| Nexus AG (NXU) | $89.06 Million | 8.51% | 0.46x | $1.24 Billion |
About NIGHTINGALE HEALTH EO 1
Nightingale Health Oyj, a health technology company, offers advanced health check that detects disease risks in Finland, the United Kingdom, rest of Europe, the United States, and internationally. The company's Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Remote Health Check where health check done remotely. It also offers blo… Read more